Evidence map›Paper›PMID 31187544›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2019

Racial differences in performance of HbA

C N Ford, R W Leet, L M Kipling, M K Rhee, S L Jackson, P W F Wilson, L S Phillips, L R Staimez

Abstract readComparative Study
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. The Expanding Role of Continuous Glucose Monitoring in the Management and Prevention of Type 2 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Oral Glucose Tolerance Test: 100 Years Later.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C N FordEmory Global Diabetes Research Centre, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0001-6730-0436
R W LeetEmory Global Diabetes Research Centre, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
L M KiplingEmory Global Diabetes Research Centre, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
M K RheeAtlanta VA Medical Centre, Decatur, GA, USA.
S L JacksonDivision for Heart Disease and Stroke Prevention, National Centre for Chronic Disease Prevention and Health Promotion, Centres for Disease Control and Prevention, Atlanta, GA, USA.
P W F WilsonAtlanta VA Medical Centre, Decatur, GA, USA.
L S PhillipsAtlanta VA Medical Centre, Decatur, GA, USA.
L R StaimezEmory Global Diabetes Research Centre, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0002-2818-1187

Funding

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Screening for IGT: Glucose Challenge vs Predictive ModelR18DK066204 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2004 to 2007
$2.9M
Prevention of Cystic Fibrosis DiabetesR01FD003527 · FDA · EMORY UNIVERSITY · PI STECENKO, ARLENE A · 2009 to 2015
$908k
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVER21DK099716 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2014 to 2015
$321k
Latent tuberculosis infection and risk of type 2 diabetes mellitus in US veteransR03AI133172 · NIAID · GEORGIA STATE UNIVERSITY · PI MAGEE, MATTHEW JAMES · 2018 to 2019
$158k
BLRD VA I01 BX003340BLRD VA I01 BX004821CSRD VA I01 CX001025CSRD VA I01 CX001737FDA HHS R01 FD003527Intramural CDC HHS CC999999NCATS NIH HHS UL1 TR002378NIAID NIH HHS R03 AI133172NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R18 DK066204NIDDK NIH HHS R21 DK099716NIDDK NIH HHS U01 DK098246NIDDK NIH HHS U34 DK091958
6 · The paper itself

Abstract

aimTo characterize differences between black and white people in optimal HbA

methodsData were included from the National Health and Nutrition Examination Survey, 2005-2014. Black and white adults (age 18-70 years) who underwent an oral glucose tolerance test and had available fasting plasma glucose, 2-h plasma glucose and HbA

resultsIn 5324 black (32.3%) and white (67.7%) individuals, Youden's index (optimal) thresholds for HbA

conclusionsConsistently higher optimal HbA

Indexed as

Racial GroupsAdultBlack PeopleBlood GlucoseDiabetes MellitusFastingFemaleGlucose IntoleranceGlucose Tolerance TestGlycated HemoglobinHumansMaleNutrition SurveysPrediabetic StateReference ValuesSensitivity and SpecificityBlood GlucoseGlycated Hemoglobin

Identifiers

PMID31187544
PMCPMC7282707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.